Metildigoxin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Metildigoxin
Medigoxin.png
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy
category
  • C
ATC code
Identifiers
Synonyms 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-12,14-Dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyl-oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one
CAS Number
PubChem CID
ChemSpider
UNII
ECHA InfoCard 100.045.705
Chemical and physical data
Formula C42H66O14
Molar mass 794.965
3D model (JSmol)
  (verify)

Metildigoxin (INN, or medigoxin BAN, or methyldigoxin) is a cardiac glycoside,[1] a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). The substance is closely related to digoxin; it differs from the latter only by an O-methyl group on the terminal monosaccharide.

References[edit]

  1. ^ Hayward, R.; Greenwood, H.; Stephens, J.; Hamer, J. (1983). "Relationship between myocardial uptake and actions in heart failure of methyldigoxin". British Journal of Clinical Pharmacology. 15 (1): 41–48. PMC 1427830Freely accessible. PMID 6849743. doi:10.1111/j.1365-2125.1983.tb01461.x.